Concepedia

Publication | Open Access

First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

DOIFull Paper Access

86

Citations

22

References

2020

Year

Malaka Ameratunga, Irene Braña, Petri Bono, Sophie Postel‐Vinay, Ruth Plummer, John Aspegrén, Timo Korjamo, Amir Snapir, Johann S. de Bono
British Journal of Cancer

Abstract

The clinical trial registration number is NCT03035591.

References

YearCitations

Page 1